Crossject SA dba Crossject USA, Inc.
CROSSJECT develops a needle-free, pre-filled, single-use auto-injector platform intended for rapid administration of emergency medications. The company focuses on device engineering, human factors, clinical development for emergency indications (epileptic seizures, acute adrenal crisis, anaphylaxis), and regulatory authorization efforts including engagement with U.S. government funding agencies.
Industries
N/A
Products
Needle-free, pre-filled, single-use auto-injector platform
A needle-free, pre-filled, single-use auto-injector platform designed for rapid delivery of emergency medications without a needle.
Needle-free, pre-filled, single-use auto-injector platform
A needle-free, pre-filled, single-use auto-injector platform designed for rapid delivery of emergency medications without a needle.
Services
Clinical development support for emergency indications
Clinical program planning and execution for device-delivered emergency therapies.
Regulatory strategy and authorization support
Regulatory planning and submission support focused on obtaining market authorization in the U.S. (FDA) and other jurisdictions.
Human factors and usability testing
User-centered testing and human factors validation for emergency-use device designs.
Clinical development support for emergency indications
Clinical program planning and execution for device-delivered emergency therapies.
Regulatory strategy and authorization support
Regulatory planning and submission support focused on obtaining market authorization in the U.S. (FDA) and other jurisdictions.
Human factors and usability testing
User-centered testing and human factors validation for emergency-use device designs.
Expertise Areas
- Needle-free auto-injector device development
- Emergency medicine therapeutics (seizure rescue, adrenal crisis, anaphylaxis)
- Clinical program design for acute indications
- Regulatory strategy for FDA authorization
Key Technologies
- Needle-free auto-injector platform
- Pre-filled drug-device combination products
- Human factors-driven device design
- Rapid parenteral delivery alternatives to needles